PT Kalbe Farma Tbk. - PTKFF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.09
+0 (0.00%)

This chart shows the closing price for PTKFF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New PT Kalbe Farma Tbk. Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PTKFF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PTKFF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for PT Kalbe Farma Tbk. in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $0.09.

This chart shows the closing price for PTKFF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in PT Kalbe Farma Tbk.. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/18/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/16/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/14/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/14/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/13/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/13/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/28/2021The Goldman Sachs GroupUpgradeNeutral ➝ Buy
(Data available from 7/13/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/15/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/14/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/13/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/15/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/14/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/14/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/13/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/13/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
PT Kalbe Farma Tbk. logo
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business; and E-health products. It operates Mitrasana Clinics, a health care service. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.
Read More

Today's Range

Now: $0.09
Low: $0.09
High: $0.09

50 Day Range

MA: $0.08
Low: $0.08
High: $0.09

52 Week Range

Now: $0.09
Low: $0.07
High: $0.11

Volume

N/A

Average Volume

4,600 shs

Market Capitalization

N/A

P/E Ratio

0.00

Dividend Yield

0.94%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of PT Kalbe Farma Tbk.?

The following Wall Street research analysts have issued reports on PT Kalbe Farma Tbk. in the last year:
View the latest analyst ratings for PTKFF.

What is the current price target for PT Kalbe Farma Tbk.?

0 Wall Street analysts have set twelve-month price targets for PT Kalbe Farma Tbk. in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for PT Kalbe Farma Tbk. in the next year.
View the latest price targets for PTKFF.

What is the current consensus analyst rating for PT Kalbe Farma Tbk.?

PT Kalbe Farma Tbk. currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for PTKFF.

What other companies compete with PT Kalbe Farma Tbk.?

How do I contact PT Kalbe Farma Tbk.'s investor relations team?

PT Kalbe Farma Tbk.'s physical mailing address is Gedung KALBE, Jakarta, Jakarta Raya. The company's listed phone number is 622142873888. The official website for PT Kalbe Farma Tbk. is www.kalbe.co.id. Learn More about contacing PT Kalbe Farma Tbk. investor relations.